Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States
| Autor: | Carlson, Josh, Foos, Volker, Kasle, Adam, Mugwagwa, Tendai, Draica, Florin, Lee Wiemken, Timothy, Nguyen, Jennifer L., Cha-Silva, Ashley, Migliaccio-Walle, Kristen, Dzingina, Mendy |
|---|---|
| Zdroj: | In Value in Health February 2024 27(2):164-172 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect